Refocusing on R&D model or redefining marketing strategy? : Anticipating sustainability for generic pharmaceutical industry
Year of publication: |
2014
|
---|---|
Authors: | Barei, Fereshteh ; Le Pen, Claude |
Published in: |
Journal of medical marketing : device, diagnostic and pharmaceutical marketing. - London [u.a.] : Sage, ISSN 1745-7904, ZDB-ID 2189085-7. - Vol. 14.2014, 2/3, p. 81-90
|
Subject: | Generics | R&D model | innovation | product risk | value creation | quality approach | Pharmaindustrie | Pharmaceutical industry | Innovation | Generika | Generic drugs | Marketingmanagement | Marketing management | Betriebliche Wertschöpfung | Value creation | Qualitätsmanagement | Quality management | Produktentwicklung | New product development |
-
Forecasting branded and generic pharmaceuticals
Nikolopoulos, Konstantinos, (2016)
-
Pharmaceutical innovation and market share : evidence from a generic market
Yousefi, Nazila, (2016)
-
Chaudhuri, Atanu, (2013)
- More ...
-
Le prix du médicament aujourd'hui et demain
Le Pen, Claude, (1995)
-
Théorie de l'utilité et mesure des états de santé : le débat QALYs - HYEs
Le Pen, Claude, (1997)
-
"Falsifiabilité" et théorie économique ou comment rendre une théorie scientifique infalsifiable
Le Pen, Claude, (1987)
- More ...